Table 3.
Number of participants
(n = 1,293, number of observations = 6,005) |
Mean difference in AAA growth per year | 95% CI | P-value | |
---|---|---|---|---|
Unadjusted model | Optimal | Reference | ||
Sub-optimal | −1.74 | −2.37 to −1.12 | <0.001 | |
Adjusted model 1 | Optimal | Reference | ||
Sub-optimal | 0.01 | −0.10–0.13 | 0.81 | |
Adjusted model 2 | Optimal | Reference | ||
Sub-optimal | 0.001 | −0.12–0.12 | 0.99 |
Optimal BP – SBP/DBP ≤140/90 mmHg and sub-optimal BP – SBP >140 or DBP >90 mmHg. Model 1 was adjusted for smoking, DM, initial diameter and sex and Model 2 was adjusted for smoking, IHD, initial diameter, sex, DM, stroke, aspirin, BB, frusemide, diuretics, ACEI and statin. Cited p-values ≈ β = interaction of time and blood pressure groups. ACEI, angiotensin converting enzyme inhibitor; BB, beta blocker; BP, blood pressure; CI, confidence interval; DBP, diastolic blood pressure; DM, diabetes mellitus; IHD, ischemic heart disease; N, sample size; SBP, systolic blood pressure. The full model is elaborated in Supplementary 1 Table 2.